Yang EH et al. have previously demonstrated that patients with subclinical or mild CAD, with serum Lp-PLA2 concentrations above the second tertile, presented with significantly worse intracoronary function, in terms of impaired flow and vasoconstriction [18]. The gene discussed is PLA2G7; the disease is coronary artery disorder.